Key result
Type-D personality was present in 56% of ovarian cancer patients receiving chemotherapy and was significantly associated with higher symptom burden and lower quality of life.
Why the study?
Does Type-D personality affect symptoms and quality of life in patients with ovarian cancer receiving chemotherapy?
Cross-Sectional (n=150)
Does Type-D personality affect symptoms and quality of life in patients with ovarian cancer receiving chemotherapy?
Type-D personality is highly prevalent in ovarian cancer patients receiving chemotherapy and is significantly associated with worse symptoms and lower quality of life.
May support Type-D screening to flag higher-burden patients; leaves open whether interventions improve outcomes.
PURPOSE: The objective of this study was to investigate the prevalence of Type-D personality and identify its relationships among the symptoms and quality of life in patients with ovarian cancer-receiving chemotherapy. METHODS: A total of 150 patients with ovarian cancer undergoing chemotherapy were recruited between December 2015 and August 2016. The subjects were assessed using the Type-D Personality Scale-14, Memorial Symptom Assessment Scale - Short Form and Functional Assessment of Cancer Therapy-General questionnaire completed through a face-to-face interview. RESULTS: About 56% of patients were classified into the Type-D personality group. This personality group showed statistically significantly higher symptoms and lower quality of life than the non-Type-D personality group. According to stepwise multiple regression, the most significant factor influencing quality of life was symptoms, followed by Type-D personality, performance status and cancer stage. CONCLUSIONS: The prevalence of Type-D personality in patients with ovarian cancer was high, and Type-D personality was significantly associated with a high symptom score and lower quality of life. Health professionals should consider Type-D personality in the assessment and intervention of symptoms and quality of life, along with performance status and cancer stage.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2017) conducted a cross-sectional in ovarian cancer receiving chemotherapy (n=150). Type-D personality vs. non-Type-D personality was evaluated on symptoms and quality of life. Type-D personality was present in 56% of ovarian cancer patients receiving chemotherapy and was significantly associated with higher symptom burden and lower quality of life.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: